Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel Inhibition

References

• SchmidtM, JacobsenJB, LashTL, BotkerHE, SorensenHT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 2012;344:e356. doi:10.1136/bmj.e35622279115
   PubMed Web of Science ®Google Scholar
• WhiteHD, ChewDP. Acute myocardial infarction. Lancet. 2008;372(9638):570–584. doi:10.1016/S0140-6736(08)61237-418707987
   PubMed Web of Science ®Google Scholar
• SlothAD, SchmidtMR, MunkK, et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J. 2014;35(3):168–175. doi:10.1093/eurheartj/eht36924031025
   PubMed Web of Science ®Google Scholar
• MurryCE, JenningsRB, ReimerKA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–1136. doi:10.1161/01.CIR.74.5.11243769170
   PubMed Web of Science ®Google Scholar
• PeartJN, HeadrickJP. Clinical cardioprotection and the value of conditioning responses. Am J Physiol Heart Circ Physiol. 2009;296(6):H1705–1720. doi:10.1152/ajpheart.00162.200919363132
   PubMed Web of Science ®Google Scholar
• HeuschG. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116(4):674–699. doi:10.1161/CIRCRESAHA.116.30534825677517
   PubMed Web of Science ®Google Scholar
• HausenloyDJ, YellonDM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev. 2007;12(3–4):217–234. doi:10.1007/s10741-007-9026-117541822
   PubMed Web of Science ®Google Scholar
• LecourS. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol. 2009;47(1):32–40. doi:10.1016/j.yjmcc.2009.03.01919344728
   PubMed Web of Science ®Google Scholar
• HausenloyDJ, YellonDM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol. 2011;8(11):619–629. doi:10.1038/nrcardio.2011.8521691310
   PubMed Web of Science ®Google Scholar
• BellRM, BotkerHE, CarrRD, et al. 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection. Basic Res Cardiol. 2016;111(4):41. doi:10.1007/s00395-016-0558-127164905
   PubMed Web of Science ®Google Scholar
• KleinbongardP, HeuschG. Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol. 2015;172(8):2010–2025. doi:10.1111/bph.1290225204973
   PubMed Web of Science ®Google Scholar
• BarhaninJ, LesageF, GuillemareE, FinkM, LazdunskiM, KvLQTRG. 1 and IsK (minK) proteins associate to form the IKS cardiac potassium current. Nature. 1996;384(6604):78–80. doi:10.1038/384078a08900282
   PubMed Web of Science ®Google Scholar
• SanguinettiMC, CurranME, ZouA, et al. Coassembly of K(V) LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996;384(6604):80–83. doi:10.1038/384080a08900283
   PubMed Web of Science ®Google Scholar
• HedegaardER, JohnsenJ, PovlsenJA, et al. Inhibition of KV7 channels protects the rat heart against myocardial ischemia and reperfusion injury. J Pharmacol Exp Ther. 2016;357(1):94–102. doi:10.1124/jpet.115.23040926869667
   PubMed Web of Science ®Google Scholar
• TestaiL, BarreseV, SoldovieriMV, et al. Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection. Cardiovasc Res. 2016;110(1):40–50. doi:10.1093/cvr/cvv28126718475
   PubMed Web of Science ®Google Scholar
• ClaycombWC, LansonNA, StallworthBS, et al. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;95(6):2979–2984. doi:10.1073/pnas.95.6.29799501201
   PubMed Web of Science ®Google Scholar
• LaursenMR, HansenJ, ElkjaerC, et al. Untargeted metabolomics reveals a mild impact of remote ischemic conditioning on the plasma metabolome and alpha-hydroxybutyrate as a possible cardioprotective factor and biomarker of tissue ischemia. Metabolomics. 2017;13(6):67. doi:10.1007/s11306-017-1202-228473744
   PubMed Web of Science ®Google Scholar
• FuglestegBN, SulemanN, TironC, et al. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol. 2008;103(5):444–453. doi:10.1007/s00395-008-0728-x18500485
   PubMed Web of Science ®Google Scholar
• JonassenAK, SackMN, MjosOD, YellonDM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89(12):1191–1198. doi:10.1161/hh2401.10138511739285
   PubMed Web of Science ®Google Scholar
• JonassenAK, MjosOD, SackMN. p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling. Biochem Biophys Res Commun. 2004;315(1):160–165. doi:10.1016/j.bbrc.2004.01.02915013440
   PubMed Web of Science ®Google Scholar
• HausenloyDJ, YellonDM. Cardioprotective growth factors. Cardiovasc Res. 2009;83(2):179–194. doi:10.1093/cvr/cvp06219218286
   PubMed Web of Science ®Google Scholar
• PovlsenJA, LofgrenB, DalgasC, JespersenNR, JohnsenJ, BotkerHE. Frequent biomarker analysis in the isolated perfused heart reveals two distinct phases of reperfusion injury. Int J Cardiol. 2014;171(1):9–14. doi:10.1016/j.ijcard.2013.11.03524315340
   PubMed Web of Science ®Google Scholar
• WangHS, PanZ, ShiW, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 1998;282(5395):1890–1893. doi:10.1126/science.282.5395.18909836639
   PubMed Web of Science ®Google Scholar
• SogaardR, LjungstromT, PedersenKA, OlesenSP, JensenBS. KCNQ4 channels expressed in mammalian cells: functional characteristics and pharmacology. Am J Physiol Cell Physiol. 2001;280(4):C859–866. doi:10.1152/ajpcell.2001.280.4.C85911245603
   PubMed Web of Science ®Google Scholar
• SunZQ, ThomasGP, AntzelevitchC. Chromanol 293B inhibits slowly activating delayed rectifier and transient outward currents in canine left ventricular myocytes. J Cardiovasc Electrophysiol. 2001;12(4):472–478. doi:10.1046/j.1540-8167.2001.00472.x11332571
   PubMed Web of Science ®Google Scholar
• GurtlerA, KunzN, GomolkaM, et al. Stain-Free technology as a normalization tool in Western blot analysis. Anal Biochem. 2013;433(2):105–111. doi:10.1016/j.ab.2012.10.01023085117
   PubMed Web of Science ®Google Scholar
• LeeS, YangY, TannerMA, LiM, HillMA. Heterogeneity in Kv7 channel function in the cerebral and coronary circulation. Microcirculation. 2015;22(2):109–121. doi:10.1111/micc.1218325476662
   PubMed Web of Science ®Google Scholar
• HausenloyDJ, LecourS, YellonDM. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal. 2011;14(5):893–907. doi:10.1089/ars.2010.336020615076
   PubMed Web of Science ®Google Scholar
• HausenloyDJ, TsangA, MocanuMM, YellonDM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol. 2005;288(2):H971–976. doi:10.1152/ajpheart.00374.200415358610
   PubMed Web of Science ®Google Scholar
• AndreadouI, BibliSI, MastromanolisE, et al. Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: insights into intracellular signaling. Int J Cardiol. 2015;184:140–151. doi:10.1016/j.ijcard.2015.01.07925703422
   PubMed Web of Science ®Google Scholar
• HelgelandE, BreivikL, SishiBJ, EngelbrechtAM, JonassenAK. Intermittent insulin treatment mimics ischemic postconditioning via MitoKATP channels, ROS, and RISK. Scand Cardiovasc J. 2015;49(5):270–279. doi:10.3109/14017431.2015.107149426156031
   PubMed Web of Science ®Google Scholar
• HeuschG, MusiolikJ, GedikN, SkyschallyA. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res. 2011;109(11):1302–1308. doi:10.1161/CIRCRESAHA.111.25560421980124
   PubMed Web of Science ®Google Scholar
• HausenloyDJ, Garcia-DoradoD, BotkerHE, et al. Novel targets and future strategies for acute cardioprotection: position paper of the european society of cardiology working group on cellular biology of the heart. Cardiovasc Res. 2017;113(6):564–585. doi:10.1093/cvr/cvx04928453734
   PubMed Web of Science ®Google Scholar
• FerdinandyP, HausenloyDJ, HeuschG, BaxterGF, SchulzR. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014;66(4):1142–1174. doi:10.1124/pr.113.00830025261534
   PubMed Web of Science ®Google Scholar
• DavidsonSM, FerdinandyP, AndreadouI, et al. Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol. 2019;73(1):89–99. doi:10.1016/j.jacc.2018.09.08630621955
   PubMed Web of Science ®Google Scholar
• HuZ, CrumpSM, ZhangP, AbbottGW. Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction. Cardiovasc Res. 2016;110(2):227–237. doi:10.1093/cvr/cvw04826952045
   PubMed Web of Science ®Google Scholar
• CorydonKK, MatchkovV, FaisR, et al. Effect of ischemic preconditioning and a Kv7 channel blocker on cardiac ischemia-reperfusion injury in rats. Eur J Pharmacol. 2020;866:172820. doi:10.1016/j.ejphar.2019.17282031760069
   PubMed Web of Science ®Google Scholar
• SchwartzPJ, WolfS. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 1978;57(6):1074–1077. doi:10.1161/01.CIR.57.6.1074639227
   PubMed Web of Science ®Google Scholar
• WangQ, CurranME, SplawskiI, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12(1):17–23. doi:10.1038/ng0196-178528244
   PubMed Web of Science ®Google Scholar
• HighamPD, FurnissSS, CampbellRW. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J. 1995;73(1):32–36. doi:10.1136/hrt.73.1.327888257
   PubMedGoogle Scholar
• HaickJM, ByronKL. Novel treatment strategies for smooth muscle disorders: targeting Kv7 potassium channels. Pharmacol Ther. 2016;165:14–25. doi:10.1016/j.pharmthera.2016.05.00227179745
   PubMed Web of Science ®Google Scholar
• KhanamiriS, SoltysinskaE, JeppsTA, et al. Contribution of Kv7 channels to basal coronary flow and active response to ischemia. Hypertension. 2013;62(6):1090–1097. doi:10.1161/HYPERTENSIONAHA.113.0124424082059
   PubMed Web of Science ®Google Scholar
• HedegaardER, NielsenBD, KunA, et al. KV 7 channels are involved in hypoxia-induced vasodilatation of porcine coronary arteries. Br J Pharmacol. 2014;171(1):69–82. doi:10.1111/bph.1242424111896
   PubMed Web of Science ®Google Scholar